SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Elizabeth Wu, Xisui Chen, Zhe Guan, Claudia Cao, Huiying Rao, Bo Feng, Melvin Chan, Sherry Fu, Andy Lin, Lai Wei, Anna S. Lok, A comparative study of patients’ knowledge about hepatitis C in the United States and in urban and rural China, Hepatology International, 2014,

    CrossRef

  2. 2
    Javier Crespo, Joaquín Cabezas, Begoña Sacristán, José L. Olcoz, Ramón Pérez, Juan De la Vega, Rosa García, Félix García-Pajares, Federico Sáez-Royuela, José M. González, Felipe Jiménez, Santiago Rodríguez, Antonio Cuadrado, María J. López-Arias, Isidro García, Ana Milla, Emilia García-Riesco, María Muñoz, Gloria Sánchez-Antolín, Francisco Jorquera, Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice, Liver International, 2014, 34, 8
  3. 3
    Jayant A. Talwalkar, Health services and policy research in hepatology, Current Opinion in Gastroenterology, 2014, 30, 3, 272

    CrossRef

  4. 4
    Alfredo Alberti, Massimo Colombo, Antonio Craxì, Mario Rizzetto, The dilemma for patients with chronic hepatitis C: Treat now or warehouse?, Digestive and Liver Disease, 2014, 46, 1, 27

    CrossRef

  5. 5
    Fabienne Marcellin, Perrine Roux, Maria Winnock, Caroline Lions, François Dabis, Dominique Salmon-Ceron, Marc-Arthur Loko, Bruno Spire, Maria Patrizia Carrieri, Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort, Expert Review of Gastroenterology & Hepatology, 2014, 8, 4, 351

    CrossRef

  6. 6
    Patricia A. Cioe, Michael D. Stein, Kittichai Promrat, Peter D. Friedmann, A Comparison of Modified Directly Observed Therapy to Standard Care for Chronic Hepatitis C, Journal of Community Health, 2013, 38, 4, 679

    CrossRef

  7. 7
    S. C. Gordon, F. M. Hamzeh, P. J. Pockros, R. S. Hoop, A. R. Buikema, E. J. Korner, N. A. Terrault, Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease, Alimentary Pharmacology & Therapeutics, 2013, 38, 7
  8. 8
    John W. Ward, The Role of Public Health in an Era of All-Oral Therapy for Hepatitis C Infection, Current Hepatitis Reports, 2013, 12, 4, 220

    CrossRef

  9. 9
    Paul M. Trembling, Sudeep Tanwar, William M. Rosenberg, Geoffrey M. Dusheiko, Treatment decisions and contemporary versus pending treatments for hepatitis C, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 12, 713

    CrossRef